RxDoctor Payments Data

Morgan Birch, DO

Family Medicine · Hazard, KYNPI 1982962874

Payments from drug & device makers

$4,780in general payments, 2019–2025

Across 100 payments — averaging $47.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$3K
  • AbbVie$896
  • Seqirus USA Inc$154
  • Indivior Inc.$134
  • Lilly USA, LLC$103
  • Merck$102
  • plus $707 from 18 others

What the payments were for

  • Speaking & faculty fees$2,64055%
  • Food & beverage$2,14045%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,780 in reported general payments places this provider in the 80th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,753
Medicare patients
38
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban97$97,636
MounjaroTirzepatide48$60,298
OzempicSemaglutide34$41,384
JardianceEmpagliflozin39$40,656
JanuviaSitagliptin Phosphate41$39,912
VraylarCariprazine Hcl21$37,824
TrulicityDulaglutide27$36,812
LinzessLinaclotide36$30,827
FarxigaDapagliflozin Propanediol27$28,162
SublocadeBuprenorphine13$26,623
LokelmaSodium Zirconium Cyclosilicate16$17,962
Repatha SureclickEvolocumab26$15,571
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$14,206
Lantus SolostarInsulin Glargine,hum.Rec.Anlog64$13,880
ShingrixVaricella-Zoster Ge/As01b/Pf69$13,601

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$26$100,765111 claims
Lilly USA, LLCMounjaro, Trulicity$103$97,11075 claims
AbbVieVraylar, Linzess$896$68,65157 claims
AstraZenecaFarxiga, Lokelma, Symbicort$58$49,77857 claims
Novo NordiskOzempic$56$41,38434 claims
MerckJanuvia$102$39,91241 claims
GSKAnoro Ellipta, Shingrix$13$27,80789 claims
Indivior Inc.Sublocade$134$26,62313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →